Claseprubart

DB22867InvestigationalProtein Based Therapies

Claseprubart is under investigation in clinical trial NCT06858579 (A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)).

Mechanism: Pharmacologically active on Complement C1s subcomponent
Curator reviewed
Code names: DNTH103

Resolves to

Compound

UNIILDW8BPL8GB

Targets

P09871C1S

What you can answer from here — as of June 27, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Claseprubart, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account